Rosatom: a test system for diagnosis of cancer

2020: Creation of a system and preproduction

On May 6, 2020 it became known of development in Russia of a test system for diagnosis of cancer on an expiratory air. It is reported on  the website  of purchases of Rosatom state corporation which selected 4.5 million rubles for production of technology.

Specialists of Radium institute of Hlopin (St. Petersburg, is included into a scientific division of Rosatom) should prepare technical specifications on production organization of test systems for noninvasive diagnosis of diseases of the digestive system using the medicines enriched with stable (non-radioactive) isotope carbon-13.

Russia developed the test for diagnosis of cancer on an expiratory air. Money for its production is already selected

A system will allow to diagnose malignant diseases of the digestive system at early stages and to estimate efficiency of the carried-out treatment. This diagnostics is based on the analysis of a ratio between isotopes carbon-13 and carbon-12 which contain in the air exhaled by the patient.

Such diagnostic complex will reduce purchase costs of the import equipment and supplies, and mainly will raise a population scope early diagnosis of the most widespread diseases of digestive organs that will significantly increase duration and quality of life of the population — it is specified in technical specifications.

By the beginning of 2020 in Russia apply the foreign test systems to diagnosis of cancer of digestive organs, but they are not enough to cover broad masses of patients. Development of Rosatom should improve a situation in this direction, however exact terms of serial start of technology by the beginning of May are not called.

Earlier the Fund of Perspective Researches (FPR) developed the hardware-software complex capable to reveal lung cancer on an expiratory air. The solution is constructed on on the basis of an artificial neural network and the olfactory analyzer.^[1]

Notes